We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Test for Cow's Milk Allergy Is Non-Invasive

By HospiMedica staff writers
Posted on 15 May 2007
A ready-to-use patch test has been developed for diagnosing cow's milk allergy. More...


A dry, disc-shaped cutaneous device system holds an active ingredient in powder form on an electrically charged plastic film that is delivered only when placed on the skin. Application of the disc creates an occlusive chamber between the disc and the skin, making the chamber's conditions humid enough to hydrate and release the active ingredient, and to open the skin's pores to better absorb the active ingredient.

Developed by DBV Technologies (Boulogne Billancourt, France) the device system, Viaskin, for the cutaneous administration of proteins and peptides is based on a new technology: Diallertest Milk. The company presented Viaskin and its applications at the BIO Business Forum on May 8, 2007, in Boston (MA, USA).

Diallertest Milk uses this technology to diagnose cow's milk protein allergy and is suitable for everyday medical practice. Practical, simple to use, and painless as it is completely non-invasive, and it can be applied directly by the parents to the child's back at home. It significantly improves the effectiveness in the diagnosis of cow's milk protein allergy. DBV is also developing Diallertest to diagnose dust mite, soy, and wheat allergies.

The milk allergy test will soon be available in the United States. DBV Technologies and Numico, a Dutch company specializing in the production and sale of nutritional foodstuffs, have announced a distribution agreement for Diallertest Milk that will extend its original network to include the entire world. Today, about 70,000 tests have already been prescribed. The test is available in Australia, France, the Middle East, and New Zealand.


Related Links:
DBV Technologies

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.